Additionally, the prevalence of ALL, along with morbidity, ASPR, and ASIR, demonstrated a significant inflection point in 2019, transitioning from an increasing to a decreasing trend.
← all excerpts
Global burden and trends of hematologic malignancies based on Global Cancer Observatory 2022 and Global Burden of Disease 2021.
1
—
—